Literature DB >> 9890461

Mitochondria and childhood liver diseases.

R J Sokol1, W R Treem.   

Abstract

The newly recognized mitochondrial hepatopathies should be considered in the differential diagnosis of acute and chronic liver disease in childhood. It may appear as neonatal liver failure, delayed onset liver failure in early childhood or as a multisystemic process. Comparison of features of several of the known primary mitochondrial hepatopathies is provided in Table 5. Secondary mitochondrial hepatopathies are examples of the critical importance of mitochondrial function in the pathogenesis of liver injury. Our improved understanding of the role of the mitochondria in cellular necrosis and apoptosis opens the way for development of new therapeutic approaches to several hepatic disorders. Primary mitochondrial hepatopathies (especially the respiratory chain defects) should be considered in any child with liver disease and neuromuscular involvement, multisystemic disease, lactic acidosis or rapidly progressive disease, and when hepatic steatosis is the dominant histologic finding on examination of a liver specimen. Current therapies are inadequate; improved therapeutic strategies are needed for these disorders. Some patients with respiratory chain defects limited to the liver have had successful liver transplantation. This field is in evolution and will undoubtedly provide new and important developments as the next millennium begins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890461     DOI: 10.1097/00005176-199901000-00005

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  10 in total

1.  Pulmonary hypertension--a new manifestation of mitochondrial disease.

Authors:  A R Barclay; G Sholler; J Christodolou; A Shun; S Arbuckle; S Dorney; M O Stormon
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients.

Authors:  Elisabeth De Greef; John Christodoulou; Ian E Alexander; Albert Shun; Edward V O'Loughlin; David R Thorburn; Vicki Jermyn; Michael O Stormon
Journal:  JIMD Rep       Date:  2011-11-04

3.  Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury.

Authors:  Amadou K S Camara; Martin Bienengraeber; David F Stowe
Journal:  Front Physiol       Date:  2011-04-12       Impact factor: 4.566

4.  Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies.

Authors:  F Diaz; S Garcia; D Hernandez; A Regev; A Rebelo; J Oca-Cossio; C T Moraes
Journal:  Gut       Date:  2007-10-19       Impact factor: 23.059

5.  Tumor necrosis factor-alpha and apoptosis signal-regulating kinase 1 control reactive oxygen species release, mitochondrial autophagy, and c-Jun N-terminal kinase/p38 phosphorylation during necrotizing enterocolitis.

Authors:  Naira Baregamian; Jun Song; C Eric Bailey; John Papaconstantinou; B Mark Evers; Dai H Chung
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

6.  Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome.

Authors:  G Engelmann; J Meyburg; N Shahbek; M Al-Ali; M H Hairetis; A J Baker; R J T Rodenburg; D Wenning; C Flechtenmacher; S Ellard; J A Smeitink; G F Hoffmann; C R Buchanan
Journal:  J Inherit Metab Dis       Date:  2008-08-16       Impact factor: 4.982

Review 7.  Mitochondrial hepatopathies: advances in genetics and pathogenesis.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

Review 8.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

9.  Hepatocerebral form of mitochondrial DNA depletion syndrome due to mutation in MPV17 gene.

Authors:  Abdulaziz AlSaman; Hoda Tomoum; Federica Invernizzi; Massimo Zeviani
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

10.  Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia.

Authors:  Hong Koh; Gun-Seok Park; Sun-Mi Shin; Chang Eon Park; Seung Kim; Seok Joo Han; Huy Quang Pham; Jae-Ho Shin; Dong-Woo Lee
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.